Passage Bio Company
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Headquarters:
Philadelphia, Pennsylvania, United States
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Technology:
Others
Founded Date:
2018
Industry:
Gene Therapy